Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Bayer recruits diabetes patients to new UK blogging team

They join healthcare professionals in contributing to company’s new Bayer Diabetes Care blog

Bayer UK diabetes blog

An extreme snowboarder and an English literature graduate, both of whom have type 1 diabetes, are among the team of bloggers Bayer has assembled for its new UK blog.

They will contribue to the Bayer Diabetes Care blog, details of which can be found in the Digital Handbook's Pharma Social Media Directory.

Bayer Diabetes Care, which markets a range of blood glucose meters including the Nintendo-compatible Diget, said its blog would include perspectives from its newly-formed BDC panel.

This group comprises healthcare professionals and people with diabetes that Bayer has recruited – and will pay – to provide blog content and comments.

They include professional snowboarder Chris Southwell and English literature graduate and 'self-confessed rebel' Lara Wahab, who both have type 1 diabetes, in common with all the BDC patient representatives.

Also on the panel are Dr Ellie Cannon, the resident GP for the Mail on Sunday and Woman Magazine and Susan Down, diabetes nurse consultant at Somerset Partnership Foundation Trust.

Encouragingly, Bayer's new blog does allow comments – a particular point of contention under UK pharma rules, although in order to post them visitors must first register for a free membership of

The Bayer Diabetes Care blog went live last month and so far topics have included triathlon training, diabetes management, and children and diabetes.

In time, Bayer said it would look to cover “everything from the day-to-day realities of diabetes management and monitoring, to personal experiences about diet and fitness”.

A spokesperson at Bayer Diabetes Care said: “We hope that the launch of the Bayer Diabetes Care blog will bring together people with diabetes and healthcare professionals by offering an insight into the treatment and management of diabetes, as well as patients' own personal experiences.

“We want the blog to act as an interactive online space where people can share their concerns and experiences with other people who have diabetes and contribute their own comments, questions and experiences.”

Pharma interest in blogs seems to have increased this year, with new ones launched or on the horizon from Lilly and Boehringer, but UK pharma blogs are very rare.

The only example to date is the Roche-sponsored My Diary From Down Under, a blog about the smear test and cervical cancer written by a UK journalist who posted updates for three weeks in June, 2011.

UK pharma blogs and the ABPI Code of Practice

Last year the UK's Prescription Medicines Code of Practice Authority (PMCPA) published informal guidance on pharma's use of digital communications that made specific mention of blogs.

The key points in the guidance were:

• If a company issues a blog then the content needs to comply with the Code

• If a company were to sponsor a blog about a medicine or a therapy area, then it would need to be careful to ensure that all of the information contributed complied with the Code and declare its sponsorship

• Pharmaceutical companies should not sponsor blogs is they are intended, or could reasonably be expected, to discuss medicines and their uses, as it would be impossible to guarantee their compliance with the Code

31st July 2012

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...